(Q54612706)

1 June 2018

title

Experience with rubella and rubella immunization in institutionalized children (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(73)80312-9

2 March 2023

0 references

1 reference

J. D. Farquhar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4768937

2 March 2023

language of work or name

English

0 references

publication date

1 July 1973

1 reference

1 June 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0022347673803129?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(73)80312-9

https://api.elsevier.com/content/article/PII:S0022347673803129?httpAccept=text/plain

2 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(73)80312-9

The Journal of Pediatrics

2 March 2023

published in

1 reference

1 June 2018

volume

83

1 reference

1 June 2018

issue

1

1 reference

1 June 2018

page(s)

51-56

1 reference

1 June 2018

Rubella: Reinfection of Vaccinated and Naturally Immune Persons Exposed in an Epidemic

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980312-9

Dilemmas presented by the attenuated rubella vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980312-9

Rubella immunization: reconsideration of our present policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980312-9

Strategy of Rubella Vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980312-9

Viral shedding in Chinese children following vaccination with HPV-77 and Cendehill-51 live attenuated rubella vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980312-9

Immunization with live attenuated rubella virus vaccine (HPV-77). Clinical and serological results in children and adolescents in Israel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980312-9

Cendehill strain of rubella vaccine: Clinical evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980312-9

Rubella-virus hemagglutination-inhibition test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980312-9

Clinical studies with experimental live rubella virus vaccine (strain HPV-77). Evaluation of vaccine-induced immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980312-9

Follow-up on reubella vaccinations and experience with subclinical reinfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980312-9

Rubella in Bermuda. Termination of an epidemic by mass vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980312-9

Rubella in an Immunized Island Population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980312-9

Attenuated rubella viruses. Laboratory and clinical characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980312-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Prevention of clinical and subclinical rubella infection. Efficacy of three HPV-77 derivative vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980312-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Two-Year Follow-Up of Rubella Vaccinees in a Public School System

series ordinal

10

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(73)80312-9

Comparative Studies of Rubella Vaccines

2 March 2023

series ordinal

12

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(73)80312-9

2 March 2023

Identifiers

1 reference

1 June 2018

1 reference

1 June 2018